Filing Details
- Accession Number:
- 0001415889-25-002498
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-01-31 16:39:32
- Reporting Period:
- 2025-01-30
- Accepted Time:
- 2025-01-31 16:39:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1117480 | Chimerix Inc | CMRX | Pharmaceutical Preparations (2834) | 330903395 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2001106 | Michelle Laspaluto | C/O Chimerix, Inc. 2505 Meridian Parkway, Suite 100 Durham NC 27713 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-01-30 | 1,015 | $4.11 | 175,237 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The shares were sold in payment of the reporting person's tax liability incurred upon the vesting of shares subject to a restricted stock unit award granted on January 17, 2023. The sales of the shares were made pursuant to an automatic sell-to-cover arrangement adopted pursuant to Rule 10b5-1 under the Exchange Act in connection with the grant of such restricted stock unit award.
Billionaire Hedge Funds
